Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Journal: Hepatology communications
Published: August 03, 2021
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2021
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
Journal: Journal for immunotherapy of cancer
Published: September 02, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Journal: Journal for immunotherapy of cancer
Published: July 06, 2020
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
Journal: Clinical lung cancer
Published: February 12, 2020
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer.
Journal: International journal of molecular sciences
Published: September 01, 2018
Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature.
Journal: Journal of medical case reports
Published: March 25, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026